SCHEMBL3848725

SCHEMBL3848725

c1ccc(C(c2ccccc2)(c2ccccc2)n2cc(-c3ccc4ncc(-c5ccccn5)n4c3)c(-c3ccc(OCCN4CCOCC4)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDR P35968 3/20 0.41
PRKAB1 Q9Y478 3/20 0.41
ACVR1 Q04771 2/20 0.41
PRKAB2 O43741 2/20 0.41
FLT1 P17948 2/20 0.41
FLT4 P35916 2/20 0.41
PRKAG1 P54619 2/20 0.41
PRKAA2 P54646 2/20 0.41
PRKAA1 Q13131 2/20 0.41
PRKAG3 Q9UGI9 2/20 0.41
PRKAG2 Q9UGJ0 2/20 0.41
TNK2 Q07912 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
SLC2A1 P11166 1/20 0.39
TGFBR2 P37173 1/20 0.39
LTA4H P09960 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3851211 0.86 SLC2A1 (0.38) TGFBR1SLC2A1TGFBR2MKNK1
SCHEMBL3855242 0.84 TGFBR1 (0.51) TGFBR1NPC1RAB9AKDRPRKAB1
SCHEMBL3854263 0.83 TGFBR1 (0.35) TGFBR1TGFBR2
SCHEMBL3846417 0.82 MKNK1 (0.53) TGFBR1MKNK1
SCHEMBL3846170 0.80 TGFBR1 (0.46) TGFBR1NPC1RAB9ATGFBR2
SCHEMBL3855867 0.80 TGFBR1 (0.40) TGFBR1TGFBR2
SCHEMBL3852272 0.80 TGFBR1 (0.41) TGFBR1NPC1RAB9ATGFBR2MKNK1
SCHEMBL3847481 0.80 TGFBR1 (0.40) TGFBR1TGFBR2FLT3
SCHEMBL3846843 0.80 TGFBR1 (0.41) TGFBR1TGFBR2
SCHEMBL3847342 0.79 MKNK1 (0.41) TGFBR1TGFBR2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed